Inspired by the life and wishes of Henry Schueler, the Henry Schueler 41 & 9 Foundation was founded to make a profound impact and change lives for the more than 3,000+ children diagnosed with high-risk, acute lymphoblastic leukemia (ALL) annually. ALL is the most common type of childhood cancer and 3 of 4 children diagnosed with leukemia are diagnosed with ALL. It’s most common in children younger than 5. The five year survival rate for children with ALL has greatly improved over time and is now 89%.
Many patients who undergo cancer treatments, as well as others who develop diabetes, lupus, and undergo organ transplants, become immuno-suppressed and subsequently are at higher risk of developing life-threatening fungal infections such as Mucormycosis, a rare but serious condition caused by a group of molds called mucormycetes.
The Foundation’s goals are to dedicate funds to address both conditions through donations and annual fundraising events. We have contributed to significant medical advances and partner with leading institutions around the country. Click here for detailed research and partnership overviews.
We are reaching our goals by allocating fundraising dollars specifically toward:
• Grants to leading national institutions for the most comprehensive analysis of Hypodiploid ALL ever performed;
• New research grants to support a study to develop diagnostic assays that will assist in early diagnosis in antifungal therapy for the treatment of Mucormycosis;
• The creation and publishing of the world’s most comprehensive and authoritative infectious disease supplement on Mucormycosis